"Major international pharma, Alfasigma licensed Br
Post# of 72440
(Total Views: 471)
Posted On: 07/24/2019 9:23:10 AM
"Major international pharma, Alfasigma licensed Brilacidin as a new drug for IBDs ulcerative proctitis and ulcerative proctosigmoiditis from Innovation Pharma for $24 million cash and 6% royalties."
So SA sees $24m total cash also.
So SA sees $24m total cash also.
(1)
(1)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Leo Took The Money and Ran
Scroll down for more posts ▼